Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis
- PMID: 35617423
- PMCID: PMC9187071
- DOI: 10.1371/journal.pmed.1004015
Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis
Abstract
Background: Healthcare workers (HCWs), particularly those from ethnic minority groups, have been shown to be at disproportionately higher risk of infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) compared to the general population. However, there is insufficient evidence on how demographic and occupational factors influence infection risk among ethnic minority HCWs.
Methods and findings: We conducted a cross-sectional analysis using data from the baseline questionnaire of the United Kingdom Research study into Ethnicity and Coronavirus Disease 2019 (COVID-19) Outcomes in Healthcare workers (UK-REACH) cohort study, administered between December 2020 and March 2021. We used logistic regression to examine associations of demographic, household, and occupational risk factors with SARS-CoV-2 infection (defined by polymerase chain reaction (PCR), serology, or suspected COVID-19) in a diverse group of HCWs. The primary exposure of interest was self-reported ethnicity. Among 10,772 HCWs who worked during the first UK national lockdown in March 2020, the median age was 45 (interquartile range [IQR] 35 to 54), 75.1% were female and 29.6% were from ethnic minority groups. A total of 2,496 (23.2%) reported previous SARS-CoV-2 infection. The fully adjusted model contained the following dependent variables: demographic factors (age, sex, ethnicity, migration status, deprivation, religiosity), household factors (living with key workers, shared spaces in accommodation, number of people in household), health factors (presence/absence of diabetes or immunosuppression, smoking history, shielding status, SARS-CoV-2 vaccination status), the extent of social mixing outside of the household, and occupational factors (job role, the area in which a participant worked, use of public transport to work, exposure to confirmed suspected COVID-19 patients, personal protective equipment [PPE] access, aerosol generating procedure exposure, night shift pattern, and the UK region of workplace). After adjustment, demographic and household factors associated with increased odds of infection included younger age, living with other key workers, and higher religiosity. Important occupational risk factors associated with increased odds of infection included attending to a higher number of COVID-19 positive patients (aOR 2.59, 95% CI 2.11 to 3.18 for ≥21 patients per week versus none), working in a nursing or midwifery role (1.30, 1.11 to 1.53, compared to doctors), reporting a lack of access to PPE (1.29, 1.17 to 1.43), and working in an ambulance (2.00, 1.56 to 2.58) or hospital inpatient setting (1.55, 1.38 to 1.75). Those who worked in intensive care units were less likely to have been infected (0.76, 0.64 to 0.92) than those who did not. Black HCWs were more likely to have been infected than their White colleagues, an effect which attenuated after adjustment for other known risk factors. This study is limited by self-selection bias and the cross sectional nature of the study means we cannot infer the direction of causality.
Conclusions: We identified key sociodemographic and occupational risk factors associated with SARS-CoV-2 infection among UK HCWs, and have determined factors that might contribute to a disproportionate odds of infection in HCWs from Black ethnic groups. These findings demonstrate the importance of social and occupational factors in driving ethnic disparities in COVID-19 outcomes, and should inform policies, including targeted vaccination strategies and risk assessments aimed at protecting HCWs in future waves of the COVID-19 pandemic.
Trial registration: The study was prospectively registered at ISRCTN (reference number: ISRCTN11811602).
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: MDT has had research collaborations with GlaxoSmithKline and Orion Pharma unrelated to the current work. KK is Director of the University of Leicester Centre for Black Minority Ethnic Health, Trustee of the South Asian Health Foundation and Chair of the Ethnicity Subgroup of the UK Government Scientific Advisory Group for Emergencies (SAGE). SC is Deputy Medical Director of the General Medical Council, UK Honorary Professor, University of Leicester. MP reports grants from Sanofi, grants and personal fees from Gilead Sciences and personal fees from QIAGEN, outside the submitted work. ALG Co-investigator on UK-REACH, which is supported by a grant from the MRC-UK Research and Innovation (MR/V027549/1) and the Department of Health and Social Care through the National Institute for Health Research (NIHR) rapid response panel to tackle COVID-19. Past funding by internal fellowships at the University of Leicester from the Wellcome Trust Institutional Strategic Support Fund (204801/Z/16/Z) and the BHF Accelerator Award (AA/18/3/ 34220). Member of Wellcome Trust Longitudinal Populations studies COVID-19 questionnaire steering group, to design national questionnaire to capture impact of COVID-19 pandemic on the population. KRA is a member of the National Institute for Health and Care Excellence (NICE) Diagnostics Advisory Committee, the NICE Decision and Technical Support Units, and is a National Institute for Health Research (NIHR) Senior Investigator Emeritus [NF-SI-0512-10159]. He has served as a paid consultant, providing unrelated methodological and strategic advice, to the pharmaceutical and life sciences industry generally, as well as to DHSC/NICE, and has received unrelated research funding from Association of the British Pharmaceutical Industry (ABPI), European Federation of Pharmaceutical Industries & Associations (EFPIA), Pfizer, Sanofi and Swiss Precision Diagnostics/Clearblue. He has also received course fees from ABPI and is a Partner and Director of Visible Analytics Limited, a health technology assessment consultancy company.
Figures


Comment in
-
Risk assessment and strategic action are required to protect at risk minority groups of healthcare workers in future COVID-19 pandemics.Evid Based Nurs. 2023 Jan;26(1):34. doi: 10.1136/ebnurs-2022-103582. Epub 2022 Oct 3. Evid Based Nurs. 2023. PMID: 36192129 No abstract available.
Similar articles
-
SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.PLoS Med. 2021 Nov 5;18(11):e1003823. doi: 10.1371/journal.pmed.1003823. eCollection 2021 Nov. PLoS Med. 2021. PMID: 34739480 Free PMC article.
-
Access to personal protective equipment in healthcare workers during the COVID-19 pandemic in the United Kingdom: results from a nationwide cohort study (UK-REACH).BMC Health Serv Res. 2022 Jul 5;22(1):867. doi: 10.1186/s12913-022-08202-z. BMC Health Serv Res. 2022. PMID: 35790970 Free PMC article.
-
Coverage, completion and outcomes of COVID-19 risk assessments in a multi-ethnic nationwide cohort of UK healthcare workers: a cross-sectional analysis from the UK-REACH Study.Occup Environ Med. 2023 Jul;80(7):399-406. doi: 10.1136/oemed-2022-108700. Epub 2023 May 23. Occup Environ Med. 2023. PMID: 37221040 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD015112. doi: 10.1002/14651858.CD015112.pub3. Cochrane Database Syst Rev. 2024. PMID: 38597249 Free PMC article.
Cited by
-
The impact of SARS-CoV-2 on healthcare workers of a large University Hospital in the Veneto Region: risk of infection and clinical presentation in relation to different pandemic phases and some relevant determinants.Front Public Health. 2023 Nov 30;11:1250911. doi: 10.3389/fpubh.2023.1250911. eCollection 2023. Front Public Health. 2023. PMID: 38098828 Free PMC article.
-
The prevalence and determinants of SARS-CoV-2 infections among healthcare workers, results of a cross-sectional study in the Silesian Voivodeship.Int J Occup Med Environ Health. 2023 May 23;36(2):201-213. doi: 10.13075/ijomeh.1896.02101. Epub 2023 Apr 24. Int J Occup Med Environ Health. 2023. PMID: 37184147 Free PMC article.
-
Factors associated with receipt of COVID-19 vaccination and SARS-CoV-2 seropositivity among healthcare workers in Albania (February 2021-June 2022): secondary analysis of a prospective cohort study.Lancet Reg Health Eur. 2023 Apr;27:100584. doi: 10.1016/j.lanepe.2023.100584. Epub 2023 Feb 27. Lancet Reg Health Eur. 2023. PMID: 37013112 Free PMC article.
-
Hesitancy for receiving regular SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis from the UK-REACH study.BMC Med. 2022 Oct 10;20(1):386. doi: 10.1186/s12916-022-02588-7. BMC Med. 2022. PMID: 36210437 Free PMC article.
-
Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants.EClinicalMedicine. 2023 Mar;57:101877. doi: 10.1016/j.eclinm.2023.101877. Epub 2023 Mar 6. EClinicalMedicine. 2023. PMID: 36969795 Free PMC article.
References
-
- Evans S, Agnew E, Vynnycky E, Stimson J, Bhattacharya A, Rooney C, et al.. The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals. Philos Trans R Soc Lond B Biol Sci. 1829;2021(376):20200268. doi: 10.1098/rstb.2020.0268 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- WT202849/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- TPP 10-008/HX/HSRD VA/United States
- AA/18/3/34220/BHF_/British Heart Foundation/United Kingdom
- MR/V027549/1/MRC_/Medical Research Council/United Kingdom
- MC_PC_19004/MRC_/Medical Research Council/United Kingdom
- NIHR301192/DH_/Department of Health/United Kingdom
- MR/P00167X/1/MRC_/Medical Research Council/United Kingdom
- ACF-2018-11-004/DH_/Department of Health/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- 204801/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- CDF-2017-10-008/DH_/Department of Health/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous